_:n76eab51b9d284f21b00601140c6bc62dxb7
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<https://www.empr.com/home/news/drugs-in-the-pipeline/risankizumab-bla-submitted-for-moderate-to-severe-plaque-psoriasis/>